Downregulation of microRNA‑374a Predicts Poor Prognosis in Human Glioma

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma

Journal of Biomedicine and Biotechnology
2012English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients

Oncotarget
Oncology
2017English

Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Downregulation of miR‑505 Promotes Cell Proliferation, Migration and Invasion, and Predicts Poor Prognosis in Breast Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Down-Regulation of MicroRNA-133 Predicts Poor Overall Survival and Regulates the Growth and Invasive Abilities in Glioma

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

Up-Regulated Oncoprotein P28GANK Correlates With Proliferation and Poor Prognosis of Human Glioma

World Journal of Surgical Oncology
SurgeryOncology
2012English

High Expression of CDCA7 Predicts Tumor Progression and Poor Prognosis in Human Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

PKM2 Regulates Neural Invasion of and Predicts Poor Prognosis for Human Hilar Cholangiocarcinoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy